glycyrrhizic acid has been researched along with Body Weight in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ML; Leng, Y; Shen, JH; Shen, Y; Tang, J; Xu, TF; Ye, YL; Yin, HZ; Zhou, Z; Zou, HJ | 1 |
| Ahmed, KA; Amin, MM; El-Haddad, AE; El-Sadek, HM; El-Sayed, MK; Gendy, AM; Soubh, A | 1 |
| An, Y; Cheng, L; Dai, H; Duan, Y; Li, P; Li, Y; Ma, Q; Ma, X; Wang, C; Wang, J; Wang, T; Zhang, M; Zhao, B | 1 |
| Duan, X; Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Sun, H; Sun, P; Sun, X; Wang, C | 1 |
| Heidarpour, M; Karimani, A; Moghaddam Jafari, A | 1 |
| Dahiya, S; Dhingra, D; Dilbaghi, N; Kaushik, A; Kim, KH; Kumar, S; Rani, R | 1 |
| Chakraborti, AS; Ray, D; Sil, R | 1 |
| Chen, JZ; Dai, Q; Li, R; Wei, ZH; Wu, H; Xie, J; Xu, B; Zhang, XL | 1 |
| Cai, TT; Chen, T; Shen, Y; Sun, Y; Xu, Q; Zhou, XB | 1 |
| Chakravarthi, S; Haleagrahara, N; Varkkey, J | 1 |
| Chen, DR; Dong, WQ; Fu, CY; Li, H; Li, Y; Li, Z; Tang, JP; Wang, P; Wei, W | 1 |
| Carmines, EL; Gaworski, CL; Lemus, R | 1 |
| Abo, T; Makino, M; Miyaji, C; Watanbe, H | 1 |
| Kim, J; Ko, G; Park, EJ; Sohn, DH | 1 |
| Harada, K; Ishida, M; Ito, H; Katayama, S; Kawasaki, H; Okubo, M; Shiota, G; Tomie, Y | 1 |
| Okabe, S; Okamoto, T | 1 |
| Lüscher, TF; Quaschning, T; Ruschitzka, F; Shaw, S | 1 |
| Fushiki, T; Kometani, T; Nakae, T; Nishimura, T; Okada, S; Takii, H | 1 |
| deGottardi, A; Enseleit, F; Hürlimann, D; Lüscher, TF; Noll, G; Quaschning, T; Rossier, MF; Ruschitzka, F; Shaw, SG | 1 |
| Amagaya, S; Iwama, H; Ogihara, Y | 1 |
| Cain, KT; Generoso, WM; Jorgenson, TA; Rushbrook, CJ; Sheu, CW | 1 |
21 other study(ies) available for glycyrrhizic acid and Body Weight
| Article | Year |
|---|---|
Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Body Weight; Diabetes Mellitus, Experimental; Fats; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Models, Molecular; Obesity; Phenylpropionates; PPAR gamma; Rats; Rats, Wistar | 2009 |
Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1/TLR4/NF-κB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats.
Topics: Animals; Apoptosis; Body Weight; Glycyrrhizic Acid; HMGB1 Protein; Huntington Disease; Inflammation; NF-kappa B; Oxidative Stress; Rats; Toll-Like Receptor 4 | 2023 |
Therapeutic effects and mechanisms study of Hanchuan Zupa Granule in a Guinea pig model of cough variant asthma.
Topics: Animals; Anti-Asthmatic Agents; Antitussive Agents; Asthma; Body Weight; Capsaicin; Cough; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Flavonoids; GATA3 Transcription Factor; Glycyrrhizic Acid; Guinea Pigs; Lung; Medicine, Chinese Traditional; Ovalbumin; Respiratory Hypersensitivity; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Toll-Like Receptor 4; Triterpenes | 2021 |
Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice.
Topics: Animals; Body Weight; Cytoprotection; Diet, High-Fat; Fatty Acids; Gene Expression Regulation; Gluconeogenesis; Glucose Tolerance Test; Glycogen; Glycyrrhizic Acid; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Size; Receptors, Cytoplasmic and Nuclear; Triglycerides | 2017 |
Protective effects of glycyrrhizin on sub-chronic diazinon-induced biochemical, hematological alterations and oxidative stress indices in male Wistar rats.
Topics: Animals; Antioxidants; Blood Cell Count; Blood Glucose; Body Weight; Diazinon; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Insecticides; Lipid Peroxides; Male; Organ Size; Organ Specificity; Oxidative Stress; Rats; Rats, Wistar; Toxicity Tests, Subchronic | 2019 |
Antidiabetic activity enhancement in streptozotocin + nicotinamide-induced diabetic rats through combinational polymeric nanoformulation.
Topics: Animals; Benzoquinones; Blood Glucose; Body Weight; Calorimetry, Differential Scanning; Diabetes Mellitus, Experimental; Drug Compounding; Female; Glycated Hemoglobin; Glycyrrhizic Acid; Hypoglycemic Agents; Lipids; Nanoparticles; Niacinamide; Polymers; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Streptozocin | 2019 |
Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Diet; Disease Models, Animal; DNA Damage; Dyslipidemias; Free Radical Scavengers; Fructose; Glucose Transporter Type 4; Glycyrrhizic Acid; Hemoglobins; Hyperglycemia; Insulin; Insulin Resistance; Lipids; Lymphocytes; Male; Metabolic Syndrome; Muscles; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Tissue Extracts | 2013 |
Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1.
Topics: Acetylcysteine; Animals; Blood Glucose; Body Weight; Bone Marrow Cells; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelial Progenitor Cells; Feedback, Physiological; Glycation End Products, Advanced; Glycyrrhizic Acid; HMGB1 Protein; Male; Mice, Inbred C57BL; Models, Biological; Monocytes; Oxidative Stress; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Up-Regulation | 2016 |
Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
Topics: Animals; Body Weight; Colitis; Colon; Crohn Disease; Cytokines; Diarrhea; Disease Models, Animal; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Humans; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Peroxidase; Trinitrobenzenesulfonic Acid | 2009 |
Cardioprotective effects of glycyrrhizic acid against isoproterenol-induced myocardial ischemia in rats.
Topics: Animals; Body Weight; Cardiotonic Agents; Dinoprost; Glutathione; Glycyrrhizic Acid; Isoproterenol; Lipid Peroxidation; Male; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2011 |
The use of albendazole and diammonium glycyrrhizinate in the treatment of eosinophilic meningitis in mice infected with Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Body Weight; Dexamethasone; Disease Models, Animal; Eosinophilia; Female; Glycyrrhizic Acid; Humans; Immunoglobulin E; Leukocyte Count; Meningitis; Mice; Mice, Inbred BALB C; Strongylida Infections; Survival Analysis; T-Lymphocytes, Regulatory; Treatment Outcome | 2013 |
Toxicologic evaluation of licorice extract as a cigarette ingredient.
Topics: Animals; Body Weight; Bone Marrow Cells; Carcinogens; Cell Survival; Glycyrrhiza; Glycyrrhizic Acid; Inhalation Exposure; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mutagenicity Tests; Mutagens; Plant Extracts; Salmonella typhimurium; Smoke; Smoking | 2005 |
Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
Topics: Animals; Antiviral Agents; Body Weight; CD3 Complex; Cysteine; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Immunophenotyping; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Splenomegaly | 1996 |
Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction.
Topics: Animals; Basidiomycota; Body Weight; Cholestasis; Common Bile Duct Diseases; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Organ Size; Pentoxifylline; Polyporaceae; Polysaccharides; Rats; Rats, Sprague-Dawley | 1997 |
Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Diethylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Liver; Liver Function Tests; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size | 1999 |
Development of anorexia in concanavalin A-induced hepatitis in mice.
Topics: Alanine Transaminase; Animals; Anorexia; Body Weight; Brain; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Eating; Female; Glycyrrhizic Acid; Hepatitis, Animal; Interleukin-1; Liver; Mice; Mice, Inbred BALB C; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Aorta; Blood Pressure; Body Weight; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Eplerenone; Glycyrrhiza; Glycyrrhizic Acid; Heart Rate; Hydroxysteroid Dehydrogenases; Hypertension; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Molecular Structure; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Plants, Medicinal; Rats; Rats, Inbred WKY; Spironolactone; Vasodilation | 2001 |
Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycyrrhizic Acid; Hypoglycemic Agents; Male; Mice | 2001 |
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acetylcholine; Animals; Blood Pressure; Body Weight; Cells, Cultured; Corticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Glycyrrhizic Acid; Heart Rate; Humans; Hydroxysteroid Dehydrogenases; Hypertension; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Phenylpropionates; Potassium Chloride; Protein Precursors; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Vascular Diseases; Vasoconstriction; Vasodilation; Vasodilator Agents; Verapamil | 2001 |
Studies of the combined use of steroid and Shosaikoto, one of the Kampohozai (Chinese traditional medicine), on pituitary adrenocortical axis function and immune responses.
Topics: Adrenal Glands; Animals; Body Weight; Corticosterone; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hemagglutinins; Hemolytic Plaque Technique; Immunity; Male; Mice; Mice, Inbred ICR; Oleanolic Acid; Organ Size; Pituitary-Adrenal System; Plant Extracts; Plants, Medicinal; Prednisolone; Rats; Rats, Inbred Strains; Rosette Formation; Sapogenins; Saponins; Spleen | 1986 |
Tests for mutagenic effects of ammoniated glycyrrhizin, butylated hydroxytoluene, and gum Arabic in rodent germ cells.
Topics: Animals; Body Weight; Butylated Hydroxytoluene; Diet; Female; Fetal Death; Food Additives; Genes, Dominant; Genes, Lethal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Gum Arabic; Male; Mice; Mutagenicity Tests; Polysaccharides; Pregnancy; Rats; Rats, Inbred Strains; Translocation, Genetic | 1986 |